NerdWallet, Inc. Class A NRDS 深 沪
已收盘 02-06 16:00:00 美东时间
10.54
+0.240
+2.33%
华盛通- 最 高10.93
- 今 开10.50
- 成交量 115.65万股
- 最 低 10.482
- 昨 收 10.30
- 总市值 7.66亿
- 52周最高 16.24
- 市盈率 静 27.36
- 换手率 1.59%
- 52周最低 7.55
- 委 比 40.17%
- 总股本 7271.32万
- 历史最高 34.44
- 量 比 1.03
- 振 幅 4.35%
- 历史最低 6.38
- 每 手 1
- 风险率 1.83%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多NerdWallet increases $50M in share buybacks
NerdWallet (NASDAQ:NRDS) announced that it has authorized an additional $50M to repurchase its Class A common stock, resulting in a total repurchase authorization of $125M. Shares +2.42%. More on Nerd...
2025-12-17 06:47
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
2025-11-11 10:49
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 10:22
Keybanc Maintains Overweight on Nerdwallet, Raises Price Target to $16
Keybanc analyst Justin Patterson maintains Nerdwallet (NASDAQ:NRDS) with a Overweight and raises the price target from $15 to $16.
2025-11-07 22:50
Kevin O'Leary Says Gen Z Is 'Rewriting The Playbook' Of Money And Love, The Shark Is Telling His Students To Do This By The Third Date
Gen Z is changing the rules of money & relationships. They're open to co-buying homes, pooling resources & discussing finances earlier. Kevin O'Leary urges couples to talk about credit & goals by the 3rd date, saying it strengthens partnerships. Co-buying is gaining traction as a way to overcome the affordability hurdle. However, it requires planning to avoid risks. Gen Z also values financial responsibility & is willing t
2025-10-05 21:31
Barclays Maintains Overweight on Nerdwallet, Lowers Price Target to $14
Barclays analyst Ross Sandler maintains Nerdwallet (NASDAQ:NRDS) with a Overweight and lowers the price target from $17 to $14.
2025-08-08 21:50
NerdWallet shares are trading lower after the company reported worse-than-expected Q2 sales results and issued Q3 sales guidance below estimates.
NerdWallet shares are trading lower after the company reported worse-than-expec...
2025-08-08 04:56
